50.55
0.36%
+0.18
Precedente Chiudi:
$50.37
Aprire:
$50.6
Volume 24 ore:
532.95K
Capitalizzazione di mercato:
$6.84B
Reddito:
$1.57B
Utile/perdita netta:
$122.87M
Rapporto P/E:
25.15
EPS:
2.01
Flusso di cassa netto:
$165.23M
1 W Prestazione:
+0.40%
1M Prestazione:
-2.07%
6M Prestazione:
+9.25%
1 anno Prestazione:
-12.33%
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 General Armistead Avenue, Audubon, PA
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-10-20 | Iniziato | ROTH MKM | Buy |
2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
2023-02-10 | Downgrade | Needham | Buy → Hold |
2023-02-10 | Downgrade | Truist | Buy → Hold |
2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-10-18 | Iniziato | Barclays | Overweight |
2022-10-12 | Iniziato | Jefferies | Buy |
2022-04-13 | Ripresa | Truist | Buy |
2022-03-28 | Iniziato | Wells Fargo | Overweight |
2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
2021-10-29 | Iniziato | Loop Capital | Buy |
2021-02-18 | Ripresa | Needham | Buy |
2020-12-08 | Iniziato | Citigroup | Buy |
2020-10-20 | Iniziato | Stifel | Hold |
2020-08-06 | Reiterato | Needham | Buy |
2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
2020-07-21 | Iniziato | Northland Capital | Market Perform |
2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
2020-05-08 | Reiterato | Needham | Buy |
2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
2020-01-08 | Iniziato | SunTrust | Buy |
2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
2019-08-02 | Reiterato | Needham | Buy |
2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
2019-05-03 | Reiterato | Needham | Buy |
2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2018-08-02 | Reiterato | Needham | Buy |
2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
2018-05-03 | Reiterato | Needham | Buy |
2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
GMED vs. PEN: Which Stock Is the Better Value Option?
Zacks Investment Research
Globus Medical Schedules First Quarter Earnings Release and Conference Call
GlobeNewswire Inc.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Zacks Investment Research
Globus Medical (GMED) Gains From New Launches Amid Macro Issues
Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research
Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
Globus Medical Inc Azioni (GMED) Dati Finanziari
Globus Medical Inc (GMED) Reddito 2024
GMED ha riportato un ricavo (TTM) di $1.57 miliardi per il trimestre terminato il 2023-12-31, un +53.34% salita anno su anno.
Globus Medical Inc (GMED) Reddito netto 2024
GMED l'utile netto (TTM) è stato di $122.87 milioni per il trimestre terminato il 2023-12-31, un -35.39% diminuire anno su anno.
Globus Medical Inc (GMED) Flusso di cassa 2024
GMED ha registrato un flusso di cassa disponibile (TTM) di $165.22 milioni per il trimestre conclusosi con 2023-12-31, un +58.23% aumento anno su anno.
Globus Medical Inc (GMED) Utile per azione 2024
L'utile per azione (TTM) di GMED è stato pari a $1.17 per il trimestre terminato il 2023-12-31, un -37.10% declino anno su anno.
Capitalizzazione:
|
Volume (24 ore):